Progranulin

Progranulin

Progranulin Molekülinformation

Molecule Name
Progranulin
Molekülalias
CLN11, GEP, GP88, PCDGF, PEPI, PGRN
Drug Development Progress
Anzahl der klinischen Arzneimittel7
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
GRN
Molekülhintergrund
Progranulin, a secreted glycoprotein, is encoded in humans by the single GRN gene. Progranulin consists of seven and a half, tandemly repeated, non-identical copies of the 12 cysteine granulin motif. Many cellular processes and diseases are associated with this unique pleiotropic factor that include, but are not limited to, embryogenesis, tumorigenesis, inflammation, wound repair, neurodegeneration and lysosome function. Haploinsufficiency caused by autosomal dominant mutations within the GRN gene leads to frontotemporal lobar degeneration, a progressive neuronal atrophy that presents in patients as frontotemporal dementia.

Progranulin Produktliste

Species
  • Human(1)
Tag
  • His Tag(1)
Host
  • HEK293(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • Yes(1)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
Progranulin
Human Progranulin Protein, His Tag, low endotoxin (MALS & SPR verified)
Human
HEK293
MALSSDS-PAGE
SPR

$360.00

100ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
GRN Gene Therapy(Eli Lilly And Company)PR-006; LY3884963Phase 2 ClinicalEli Lilly And Company
Frontotemporal Dementia
Details
TAK-594DNL-593; PTV:PGRN; TAK-594Phase 2 ClinicalDenali Therapeutics Inc
Frontotemporal Dementia
Details
AVB-101AVB-101Phase 2 ClinicalAviadoBio Ltd
Frontotemporal Dementia
Details
NivisnebartAL-101; GSK-4527226Phase 2 ClinicalAlector Inc
Alzheimer Disease; Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Nerve Degeneration; Parkinson Disease
Details
PBFT-02PBFT-02Phase 2 ClinicalUniversity Of Pennsylvania
Frontotemporal Dementia
Details
VGN-R13VGN-R13Phase 1 ClinicalShanghai Vitalgen BioPharma Co Ltd
Amyotrophic Lateral Sclerosis
Details
AG-01(A&G Pharm)AG-01(A&G Pharm)Phase 1 ClinicalA&G Pharmaceutical
Carcinoma, Non-Small-Cell Lung; Mesothelioma; Triple Negative Breast Neoplasms
Details
Customer Reviews